YIRAN CHEN

YIRAN CHEN


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
晓L晓晨 li
晓晨 li
ZWZhimin Wang
Zhimin Wang
YCYIRAN CHEN
YIRAN CHEN
YYYing Yang
Ying Yang
HSHanrui Shao
Hanrui Shao
YRYanling Ren
Yanling Ren

28 December 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
QGQianxi Ge
Qianxi Ge
ZWZhimin Wang
Zhimin Wang
JYJiaxiang Yu
Jiaxiang Yu
XFXiuzhi Feng
Xiuzhi Feng
JLJiquan Li
Jiquan Li
YCYIRAN CHEN
YIRAN CHEN
Ferroptosis is linked to various pathological conditions; however, the specific targets and mechanisms through which traditional Chinese medicine influences ischemic stroke (IS)-induced ferroptosis remain poorly understood. In this study, data from the Gene Expression Omnibus and disease target databases (OMIM, GeneCards, DisGeNet, TTD, and DrugBank) were integrated with ferroptosis-related gene datasets. To identify key molecular targets of Chuanxiong Rhizoma (CX), drug ingredient databases, including PubChem and TCMBank, were employed to map CX-related targets (CX-DEGs-FRG and CX-IS-FRG). Gene targets and relevant signaling pathways were analyzed using weighted gene co-expression network analysis, protein-protein interaction networks, Gene Ontology, and Kyoto Encyclopedia of Genes and Genomes pathway enrichment. The least absolute shrinkage and selection operator regression and support vector machine methods were utilized to identify intersecting genes, and the predictive accuracy of core targets was evaluated through receiver operating characteristic curve analysis. Immune cell infiltration in the IS microenvironment was assessed using CIBERSORT, followed by molecular docking of CX’s active components with key targets. The JAK-STAT3 pathway was identified as a critical regulatory mechanism, and five key targets (ALOX5, PTGS2, STAT3, G6PD, and HIF1A) emerged as central to the IS-induced ferroptosis. Elevated infiltration of CD8 + T cells and neutrophils was significantly correlated with IS. Notably, the active components mandenol and myricanone demonstrated strong binding affinities with these five targets, which validated the results from network-based analysis. In conclusion, the JAK-STAT3 pathway, through its regulation of ALOX5, PTGS2, STAT3, G6PD, and HIF1A, could play a crucial role in modulating ferroptosis and immune responses in IS. These findings suggest that CX could serve as a potential therapeutic approach for IS, targeting the regulation of IS-induced ferroptosis and the immune microenvironment.

11 May 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Open access
ZZZhuo Zhao
Zhuo Zhao
JLJiayun Li
Jiayun Li
NSNan Song
Nan Song
HGHao Gao
Hao Gao
DLDonglin Liu
Donglin Liu
XYXiao Yang
Xiao Yang
Buzhong Yiqi decoction (BZYQ), a compound formula comprising eight traditional Chinese medicinal herbs, has been used clinically to treat various autoimmune diseases, including autoimmune thyroiditis (AIT). Our long-term clinical practice and research have shown that BZYQ demonstrates promising anti-inflammatory efficacy in the management of AIT, and the underlying pharmacological mechanisms involved warrant further exploration. To investigate the therapeutic effects and underlying mechanisms of the impact of BZYQ on AIT both in vitro and in vivo. An AIT model was developed in NOD.H-2h4 mice by administering 0.05 % NaI. The therapeutic efficacy of BZYQ on AIT was evaluated using hematoxylin-eosin (H&E) staining and enzyme-linked immunosorbent assay(ELISA). Oxidative stress and inflammation-related parameters, including superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) were analyzed. Thyroid cell apoptosis was observed using TUNEL staining. Reverse transcription-quantitative polymerase chain reaction(RT-qPCR), Western blotting, immunohistochemistry, and immunofluorescence were performed. These techniques were used to determine the alterations in key genes and proteins involved in the sirtuin 1 (SIRT1)-mediated Nuclear factor (erythroid-derived 2)-like 2 (Nrf2)/nuclear factor-kappaB p65 (NF-κB p65) axis regulating the apoptotic pathway in thyroid tissues of AIT mice after BZYQ intervention. Furthermore, lipopolysaccharide(LPS)was used to create a cellular model, which was then treated with BZYQ-containing serum. Confirmatory studies were conducted using a SIRT1 inhibitor. The protein levels of SIRT1, Nrf2, NF-κB p65, and Caspase-3 in Nthy-ori 3-1 cells were analyzed to gain further mechanistic insights. BZYQ ameliorated thyroid pathology in AIT mice, reduced inflammatory cell infiltration, lowered inflammation scores, decreased serum levels of TGAb and TPOAb antibodies, and diminished the spleen index. These findings suggest that BZYQ has a protective effect against thyroid damage in AIT. BZYQ-M exhibited the most pronounced therapeutic efficacy. Mechanistically, BZYQ exerted its anti-inflammatory, antioxidant, and antiapoptotic effects by upregulating SIRT1, which subsequently promoted Nrf2 expression and inhibited NF-κB p65 activation. These changes led to altered protein expression and mRNA levels of its downstream targets, considerably suppressing the production of inflammatory cytokines (TNF-α and IL-6), attenuating oxidative stress (MDA, SOD, and CAT), regulating the expressions of apoptotic markers (Bax, Bcl-2, CytC, and Caspase-3), and reducing the apoptosis rate of thyroid cells. Further validation via in vitro experiments revealed that SIRT1 inhibitors can block the protective effects of BZYQ on the Sirt1-mediated Nrf2/NF-κB axis and cellular apoptosis. The findings from this study establish that BZYQ exhibits potent antioxidant and anti-inflammatory activities via the SIRT1-mediated Nrf2/NF-κB p65 axis, reducing thyroid cell apoptosis. These observations unveil a novel mechanism and support the potential of BZYQ as a promising therapeutic agent for AIT.